Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Revenue | 273.33% | 573.08% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 273.33% | 573.08% | -- | -- | -- |
| Cost of Revenue | 17.97% | 77.35% | -- | -- | 1,000.00% |
| Gross Profit | 386.90% | 938.42% | -- | -- | 2,571.43% |
| SG&A Expenses | -51.06% | -59.10% | -74.09% | -78.64% | -68.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -47.25% | -55.99% | -72.22% | -77.53% | -67.47% |
| Operating Income | 72.84% | 76.32% | 81.05% | 82.38% | 69.87% |
| Income Before Tax | -53.69% | 14.33% | 48.73% | 66.78% | 45.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.69% | 14.33% | 48.73% | 66.78% | 45.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.13% | 8.21% | 52.30% | 69.81% | 48.77% |
| EBIT | 72.84% | 76.32% | 81.05% | 82.38% | 69.87% |
| EBITDA | 75.88% | 78.19% | 81.66% | 82.61% | 70.11% |
| EPS Basic | 76.97% | 75.96% | 84.62% | 91.01% | 91.32% |
| Normalized Basic EPS | 78.42% | 82.82% | 92.36% | 94.66% | 92.85% |
| EPS Diluted | 76.97% | 75.96% | 84.62% | 91.01% | 91.32% |
| Normalized Diluted EPS | 78.42% | 82.82% | 92.36% | 94.66% | 92.85% |
| Average Basic Shares Outstanding | 5,367.73% | 3,399.34% | 935.53% | 163.27% | 358.23% |
| Average Diluted Shares Outstanding | 5,367.73% | 3,399.34% | 935.53% | 163.27% | 358.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
